Splenic artery embolization for treatment of portal hypertension due to essential thrombocythemia
Portal Hypertension & Cirrhosis · 2022
DOI: 10.1002/poh2.25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Portal Hypertension & Cirrhosis, 2022. Verfasst von Jiacheng Liu und 2 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Philadelphia‐negative myeloproliferative neoplasms (MPNs) are significantly associated with the development of splanchnic vein thrombosis, which leads to portal hypertension. Here, we report two rare cases of portal hypertension caused by essential thrombocythemia (a type of MPN). Splenic artery embolization was performed to prevent variceal rebleeding, and during follow‐up, no rebleeding occurred in these two cases.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, J., Liu, X., & Xiong, B. (2022). Splenic artery embolization for treatment of portal hypertension due to essential thrombocythemia. Portal Hypertension & Cirrhosis. https://doi.org/10.1002/poh2.25
Vancouver
Liu J, Liu X, Xiong B. Splenic artery embolization for treatment of portal hypertension due to essential thrombocythemia. Portal Hypertension & Cirrhosis. 2022. doi:10.1002/poh2.25
BibTeX
@article{Liu2022,
author = {Liu, Jiacheng and Liu, Xiaoming and Xiong, Bin},
title = {Splenic artery embolization for treatment of portal hypertension due to essential thrombocythemia},
journal = {Portal Hypertension & Cirrhosis},
year = {2022},
doi = {10.1002/poh2.25}
}
EUVIMED